Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

ArticleinPsychopharmacology 167(2):219-20 · June 2003with19 Reads
Impact Factor: 3.88 · DOI: 10.1007/s00213-003-1396-z · Source: PubMed